Home›Companies›Biotech & Pharma›Ambient Biosciences

Ambient Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 2, 2024·Suggest an edit

About Ambient Biosciences

Ambient Biosciences is a private company based in Ann Arbor, Michigan. It has reported $24,310,003 raised in four offerings on Form D since September 2018. Its chief executive is Richard Troyer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 22, 2024Dec 2, 2024$4,160,002of $5.0M target9$462KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Mar 31, 2023Apr 13, 2023$9,150,001of $12.1M target8$1.1MEquityRule 506(b)Form D ↗
Dec 1, 2021Dec 7, 2021$4,000,000fully sold1$4.0MDebt, Convertible notes and the equity securities issuable upon any conversion thereofRule 506(b)Form D ↗
Sep 6, 2018Sep 20, 2018$7,000,000fully sold1$7.0MEquityRule 506(b)Form D ↗
Total, four offerings$24,310,003

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ambient Biosciences's Form D filed Dec 2, 2024.

PM
Paul Meister
Director
MC
Matthew Cobbett
Executive officer
PM
Pravansu Mohanty
Executive officer and director
JH
Jack Hoppin
Director
CM
Craig Manson
Executive officer
WP

Earlier filings also listed Carl Le Souef (executive officer and director, last listed Dec 2021), Alan Turfe (executive officer, last listed Dec 2021) and Steve Annear (vice president, last listed Sep 2018).

Sources

  1. SECAmbient Biosciences, Inc. filing history